ARTICLE | Company News
Isis Pharmaceuticals, AstraZeneca deal
November 24, 2014 8:00 AM UTC
Isis received a $7.5 million milestone payment from AstraZeneca under a December 2012 deal to discover antisense therapeutics against four undisclosed cancer targets from AZ. The payment was triggered...